|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1648 SEK | +1.10% |
|
+3.26% | -32.87% |
| Feb. 23 | Abliva AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
| 2023 | Abliva AB Reaches Patient Enrollment Goal for Wave 1 of the FALCON Study | CI |
Abliva AB (publ) reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was SEK 1.06 million. Net loss was SEK 16.09 million compared to SEK 22.03 million a year ago.
Basic loss per share from continuing operations was SEK 0.02 compared to SEK 0.05 a year ago. Diluted loss per share from continuing operations was SEK 0.02 compared to SEK 0.05 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -32.87% | 20.28M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
ABLIVA AB 
